Viewing Study NCT01909557


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-02-20 @ 6:43 PM
Study NCT ID: NCT01909557
Status: COMPLETED
Last Update Posted: 2013-07-26
First Post: 2013-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.
Sponsor: University of Catania
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Quality of Life View
None Daily Activity View
None Fatigue View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acetyl-L-carnitine View
None Interferons View
None Ribavirin View
None Hepatitis C View
None Fatigue View